rs587776931
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_020699.4(GATAD2B):c.1408C>T(p.Gln470*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
GATAD2B
NM_020699.4 stop_gained
NM_020699.4 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 9.97
Genes affected
GATAD2B (HGNC:30778): (GATA zinc finger domain containing 2B) This gene encodes a zinc finger protein transcriptional repressor. The encoded protein is part of the methyl-CpG-binding protein-1 complex, which represses gene expression by deacetylating methylated nucleosomes. Mutations in this gene are linked to intellectual disability and dysmorphic features associated with cognitive disability. [provided by RefSeq, Jun 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-153813261-G-A is Pathogenic according to our data. Variant chr1-153813261-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 39665.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr1-153813261-G-A is described in Lovd as [Pathogenic]. Variant chr1-153813261-G-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATAD2B | NM_020699.4 | c.1408C>T | p.Gln470* | stop_gained | 8/11 | ENST00000368655.5 | NP_065750.1 | |
GATAD2B | XM_047426115.1 | c.1411C>T | p.Gln471* | stop_gained | 8/11 | XP_047282071.1 | ||
GATAD2B | XM_047426117.1 | c.1408C>T | p.Gln470* | stop_gained | 8/11 | XP_047282073.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATAD2B | ENST00000368655.5 | c.1408C>T | p.Gln470* | stop_gained | 8/11 | 1 | NM_020699.4 | ENSP00000357644.4 | ||
GATAD2B | ENST00000634544.1 | c.1408C>T | p.Gln470* | stop_gained | 8/11 | 5 | ENSP00000489184.1 | |||
GATAD2B | ENST00000634408.1 | c.1360C>T | p.Gln454* | stop_gained | 8/11 | 5 | ENSP00000489595.1 | |||
GATAD2B | ENST00000634564.1 | c.661C>T | p.Gln221* | stop_gained | 3/5 | 5 | ENSP00000489309.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2020 | The alteration results in a premature stop codon: _x000D_ _x000D_ The c.1408C>T (p.Q470*) alteration, located in exon 8 (coding exon 7) of the GATAD2B gene, results from a C to T substitution at nucleotide position 1408. This changes the amino acid from a glutamine (Q) to a stop codon at amino acid position 470. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. The alteration is not observed in population databases: _x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the GATAD2B c.1408C>T alteration was not observed, with coverage at this position. The alteration has been observed in affected individuals:_x000D_ _x000D_ This alteration was previously detected de novo in two unrelated patients with intellectual disability (de Ligt, 2012; Kosmicki, 2017). Based on the available evidence, this alteration is classified as pathogenic. - |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 15, 2012 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at